| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2)
|
Mohrmann, Karin
|
|
2005
|
56 |
4 |
p. 344-350
|
article
|
| 2 |
Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum
|
Dias, Paulo Fernando
|
|
2005
|
56 |
4 |
p. 436-446
|
article
|
| 3 |
Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism
|
de Jonge, Milly E.
|
|
2005
|
56 |
4 |
p. 370-378
|
article
|
| 4 |
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer
|
Boccardo, Francesco
|
|
2005
|
56 |
4 |
p. 415-420
|
article
|
| 5 |
Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry
|
Payne, Geoffrey S
|
|
2005
|
56 |
4 |
p. 409-414
|
article
|
| 6 |
Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions
|
Anderson, Lawrence W.
|
|
2005
|
56 |
4 |
p. 351-357
|
article
|
| 7 |
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer
|
Desai, Apurva A.
|
|
2005
|
56 |
4 |
p. 421-426
|
article
|
| 8 |
Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis
|
Dutta, Tania
|
|
2005
|
56 |
4 |
p. 427-435
|
article
|
| 9 |
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss
|
Jamieson, SMF
|
|
2005
|
56 |
4 |
p. 391-399
|
article
|
| 10 |
Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells
|
Liu, Jiajun
|
|
2005
|
56 |
4 |
p. 400-408
|
article
|
| 11 |
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study
|
Pappas, Periklis
|
|
2005
|
56 |
4 |
p. 358-360
|
article
|
| 12 |
Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin
|
Hess, Suzanne M.
|
|
2005
|
56 |
4 |
p. 337-343
|
article
|
| 13 |
Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer
|
Bruno, Rene
|
|
2005
|
56 |
4 |
p. 361-369
|
article
|
| 14 |
Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice
|
Chou, Ting-Chao
|
|
2005
|
56 |
4 |
p. 379-390
|
article
|
| 15 |
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors
|
Kobayashi, Hiroyuki
|
|
2005
|
56 |
4 |
p. 329-336
|
article
|
Journal description